Clinical Trial Update: Effects of 3 Months of Selective Serotonin Reuptake Inhibitor (SSRI)-Treatment on Metabolism and Hypothalamic-pituitary-adrenal (HPA)-Axis in Young Men Born With Low Birth Weight [NA]

View source ↗

Summary

A completed clinical trial examined the effects of three months of SSRI treatment on metabolism and the HPA axis in young men born with low birth weight.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Cardiovascular Disease
• Insulin Resistance
• Major Depressive Disorder
• Type 2 Diabetes Mellitus

Drugs mentioned

• Selective serotonin reuptake inhibitor (SSRI)

Snippet

Sponsor: University of Aarhus | Conditions: Insulin Resistance, Low Birth Weight | NA | Status: COMPLETED